Literature DB >> 12633120

Can long-term treatment with antidepressant drugs worsen the course of depression?

Giovanni A Fava1.   

Abstract

BACKGROUND: The possibility that antidepressant drugs, while effectively treating depression, may worsen its course has received inadequate attention.
METHOD: A review of the literature suggesting potential depressogenic effects of long-term treatment with antidepressant drugs was performed. A MEDLINE search was conducted using the keywords tolerance, sensitization, antidepressive agents, and switching. This was supplemented by a manual search of Index Medicus under the heading "antidepressant agents" and a manual search of the literature for articles pointing to paradoxical effects of antidepressants.
RESULTS: A number of reported clinical findings point to the following possibilities: very unfavorable long-term outcome of major depression treated by pharmacologic means, paradoxical (depression-inducing) effects of antidepressant drugs in some patients with mood and anxiety disturbances, antidepressant-induced switching and cycle acceleration in bipolar disorder, occurrence of tolerance to the effects of antidepressants during long-term treatment, onset of resistance upon rechallenge with the same antidepressant drug in a few patients, and withdrawal syndromes following discontinuation of mood-elevating drugs. These phenomena in susceptible individuals may be explained on the basis of the oppositional model of tolerance. Continued drug treatment may recruit processes that oppose the initial acute effects of a drug and may result in loss of clinical effect. When drug treatment ends, these processes may operate unopposed, at least for some time, and increase vulnerability to relapse.
CONCLUSION: The possibility that antidepressant drugs may worsen the course of depression needs to be tested, even though its scientific exploration is likely to encounter considerable methodological and ideological difficulties. The clinical implications of this hypothesis in depression are considerable. Antidepressant drugs are crucial in the treatment of major depressive episodes. However, appraisal of paradoxical effects that may occur in susceptible patients during long-term treatment may lead to more effective use of the drugs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12633120     DOI: 10.4088/jcp.v64n0204

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  32 in total

1.  A Case of Major Depressive Disorder With Mixed Features: Diagnostic and Treatment Issues.

Authors:  Verinder Sharma; Rudy Bowen; Priya Sharma
Journal:  Prim Care Companion CNS Disord       Date:  2015-07-30

2.  Risk factors for relapse and recurrence of depression in adults and how they operate: A four-phase systematic review and meta-synthesis.

Authors:  J E J Buckman; A Underwood; K Clarke; R Saunders; S D Hollon; P Fearon; S Pilling
Journal:  Clin Psychol Rev       Date:  2018-07-29

3.  [Should treatment of mild depression be exclusively psychotherapeutic? For].

Authors:  H Schauenburg; T Bschor
Journal:  Nervenarzt       Date:  2013-03       Impact factor: 1.214

4.  General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.

Authors:  Thomas C Baghai; Pierre Blier; David S Baldwin; Michael Bauer; Guy M Goodwin; Kostas N Fountoulakis; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan Stein; Marcio Versiani; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11       Impact factor: 5.270

5.  Effect of Reminder Devices on Medication Adherence: The REMIND Randomized Clinical Trial.

Authors:  Niteesh K Choudhry; Alexis A Krumme; Patrick M Ercole; Charmaine Girdish; Angela Y Tong; Nazleen F Khan; Troyen A Brennan; Olga S Matlin; William H Shrank; Jessica M Franklin
Journal:  JAMA Intern Med       Date:  2017-05-01       Impact factor: 21.873

Review 6.  Identification and treatment of antidepressant tachyphylaxis.

Authors:  Steven D Targum
Journal:  Innov Clin Neurosci       Date:  2014-03

Review 7.  Treatment of recurrent depression: a sequential psychotherapeutic and psychopharmacological approach.

Authors:  Giovanni A Fava; Chiara Ruini; Nicoletta Sonino
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

8.  Agomelatine: The evidence for its place in the treatment of depression.

Authors:  Daniela Eser; Thomas C Baghai; Hans-Jürgen Möller
Journal:  Core Evid       Date:  2010-06-15

Review 9.  Treatment resistant depression: A multi-scale, systems biology approach.

Authors:  Huda Akil; Joshua Gordon; Rene Hen; Jonathan Javitch; Helen Mayberg; Bruce McEwen; Michael J Meaney; Eric J Nestler
Journal:  Neurosci Biobehav Rev       Date:  2017-08-30       Impact factor: 8.989

10.  Assessing rates and predictors of tachyphylaxis during the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) study.

Authors:  Anthony J Rothschild; Boadie W Dunlop; David L Dunner; Edward S Friedman; Alan Gelenberg; Peter Holland; James H Kocsis; Susan G Kornstein; Richard Shelton; Madhukar H Trivedi; John M Zajecka; Corey Goldstein; Michael E Thase; Ron Pedersen; Martin B Keller
Journal:  Psychopharmacol Bull       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.